mrna

Search on Google

Merck and Moderna report that a personalized mRNA vaccine helped prevent skin cancer from returning in high-risk patients. Observers greeted the news with enthusiasm but noted that full data from the ongoing late-stage study has yet to be released.

Trending in 5 countries:

Peak volume

2K+

First seen

2026-08-19

Last seen

2026-08-19

Days trending

1 / 1

Countries

Trending timeline

2026-08-19

2000+

Latest related news (2026-08-19)

Merck and Moderna say mRNA melanoma vaccine hits goals in late-stage trial — CBC
Moderna’s 160% Surge Burns Shorts in ‘Painful’ $5 Billion Loss — Bloomberg.com
Moderna Stock Explodes Over 100% After Cancer Vaccine Breakthrough — Yahoo Finance